Literature DB >> 10540352

Domain deletions in the human polymeric Ig receptor disclose differences between its dimeric IgA and pentameric IgM interaction.

I N Norderhaug1, F E Johansen, P Krajci, P Brandtzaeg.   

Abstract

The human polymeric Ig receptor (pIgR), or transmembrane secretory component, is basolaterally expressed on secretory epithelial cells; its function is to transport externally J chain-containing dimeric IgA and pentameric IgM. The ligand-binding extracellular part of this receptor contains five disulfide-stabilized domains which show considerable homology with the variable domains of Ig chains. The N-terminal domain 1 (D1) mediates the initial noncovalent ligand interaction. In this study we made deletions of the human pIgR D2 and D3 (pIgRDelta2,3), or D4 and D5 (pIgRDelta4,5), to investigate the influence of these domains in receptor binding and transport of dimeric IgA and pentameric IgM across MDCK cells transfected with the truncated receptors. Both mutants were found to bind pentameric IgM, but only pIgRDelta4,5 bound dimeric IgA. These results showed that the two ligands interact differently with human pIgR; binding of pentameric IgM apparently depends fully on strong interactions with D1, while binding of dimeric IgA in addition depends on elements within D2 and / or D3 to support the initial noncovalent binding to D1. Moreover, our studies imply that dimeric human IgA binds differently to pIgR from various species. This observation cautions against interpretation of functional studies performed with non-homologous receptor-ligand pairs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540352     DOI: 10.1002/(SICI)1521-4141(199910)29:10<3401::AID-IMMU3401>3.0.CO;2-G

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodies.

Authors:  Stéphanie Longet; Sarah Miled; Marius Lötscher; Sylvia M Miescher; Adrian W Zuercher; Blaise Corthésy
Journal:  J Biol Chem       Date:  2012-12-18       Impact factor: 5.157

2.  Structural requirements for the interaction of human IgM and IgA with the human Fcalpha/mu receptor.

Authors:  Ashfaq Ghumra; Jianguo Shi; Richard S Mcintosh; Ingunn B Rasmussen; Ranveig Braathen; Finn-Eirik Johansen; Inger Sandlie; Patricia K Mongini; Thomas Areschoug; Gunnar Lindahl; Melanie J Lewis; Jenny M Woof; Richard J Pleass
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

Review 3.  The B-cell system of human mucosae and exocrine glands.

Authors:  P Brandtzaeg; I N Farstad; F E Johansen; H C Morton; I N Norderhaug; T Yamanaka
Journal:  Immunol Rev       Date:  1999-10       Impact factor: 12.988

4.  Fc receptors for immunoglobulins and their appearance during vertebrate evolution.

Authors:  Srinivas Akula; Sayran Mohammadamin; Lars Hellman
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

Review 5.  Immunoglobulin Transporting Receptors Are Potential Targets for the Immunity Enhancement and Generation of Mammary Gland Bioreactor.

Authors:  Xuemei Jiang; Jianjun Hu; Diraviyam Thirumalai; Xiaoying Zhang
Journal:  Front Immunol       Date:  2016-06-10       Impact factor: 7.561

Review 6.  Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next?

Authors:  Katelyn Jones; Anca F Savulescu; Frank Brombacher; Sabelo Hadebe
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.